Medline MDLN
NASDAQ MDLN
$34.94 +0.24 (+0.69%)
At close: Oct 1, 2026 · 4:00 PM EDT

Medline (MDLN) Return on Equity [ROE] (2026)

Updated

Medline's Return on Equity [ROE] came in at 5.38% for Q2 2026.

Analysis

Medline (MDLN) Return on Equity [ROE] (2026) Analysis & Trends

For FY2025, Medline's Return on Equity [ROE] was 6.53%, down 0.77 percentage points from FY2024.

  • Going back by year, Return on Equity [ROE] was 7.29% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 Medline 45.62 Bn 46.07 Bn 2.22 Bn 5.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 5.38%
API Access

Medline Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MDLN&period=max&api_key=YOUR_API_KEY